Autoimmune Gastrointestinal Dysmotility (AGID) Evaluation

Summary

April 2012

In summary, the autoimmune gastrointestinal dysmotility serological evaluation aids the investigation of new onset idiopathic gastrointestinal dysmotility. Detection of 1 or more of this profile of autoantibodies may lead to detection of unsuspected cancer and seropositivity will indicate a potentially immunotherapy responsive disorder.

< Previous Slide

Summary

Next Slide >

 

Jump to section:

• Introduction
• New Profile
• AGID
• Symptoms
• AGID¹
• AGID^1,2
• AGID: Laboratory Findings
• AGID: Antibody Evaluation
• Ganglionic Acetylcholine Receptor (AChR) Autoantibody^3,4
• Ganglionic AChR Autoantibody
• AGID Antibody Profile
• AGIDE/89886 Algorithm
• AGIDE/89886 Algorithm
• AGIDE/89886 Algorithm
• AGIDE/89886 Algorithm
• Clinical Utility of AGID Evaluation
• Clinical Utility of AGID Evaluation
• Summary
• References
• Questions